Page last updated: 2024-09-04

disopyramide, (s)-isomer and pulmicort

disopyramide, (s)-isomer has been researched along with pulmicort in 2 studies

Compound Research Comparison

Studies (disopyramide, (s)-isomer)	Trials (disopyramide, (s)-isomer)	Recent Studies (post-2010) (disopyramide, (s)-isomer)	Studies (pulmicort)	Trials (pulmicort)	Recent Studies (post-2010) (pulmicort)
5	0	0	4,995	1,638	1,785

Protein Interaction Comparison

Protein	Taxonomy	pulmicort (IC50)
Glucocorticoid receptor	Homo sapiens (human)	0.0026
Progesterone receptor	Homo sapiens (human)	0.028
Glucocorticoid receptor	Rattus norvegicus (Norway rat)	0.0029
Glycine receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.0045
Mineralocorticoid receptor	Homo sapiens (human)	0.014
Matrix metalloproteinase-9	Homo sapiens (human)	1.989
Androgen receptor	Rattus norvegicus (Norway rat)	1.1725
Glycine receptor subunit beta	Rattus norvegicus (Norway rat)	0.0045
Glycine receptor subunit alpha-2	Rattus norvegicus (Norway rat)	0.0045
Glycine receptor subunit alpha-3	Rattus norvegicus (Norway rat)	0.0045

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1

Other Studies

2 other study(ies) available for disopyramide, (s)-isomer and pulmicort

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008

Article

Year

Hologram QSAR model for the prediction of human oral bioavailability.

Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007

Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008